Mark Pittelkow is a Dermatology physician affiliated with Mayo Clinic in Arizona. OpenAlex indexes 516 publications with 27,474 citations (h-index 89); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 1% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13400 E Shea Blvd
Scottsdale, AZ 85259
Telephone
480-301-8508Provider last certified this registry record 3 Sept 2020.
Clinical trials
- Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer
Sponsor: Mayo Clinic
- Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation
Sponsor: Alliance for Clinical Trials in Oncology
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- LEO Pharma Inc.Program year20251 payment
- Kyowa Kirin, Inc.Program year20242 payments
- E.R. Squibb & Sons, L.L.C.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
22.1%Azole Antifungal15.6%Ketoconazole100%Part D≥59 patientsTetracycline-class Drug3.3%Doxycycline Monohydrate100%Part D≥13 patients+ 1 more class in this area
Dermatology
22%Corticosteroid16.9%Triamcinolone Acetonide100%Part D≥86 patientsInterleukin-4 Receptor alpha Antagonist3.1%Dupixent Syringe100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
21%Nucleoside Metabolic Inhibitor10.5%Fluorouracil100%Part D≥76 patientsPorphyrin Precursor7.4%Aminolevulinic acid hcl100%Part B, office-administered≥40 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Caselli, MD
Mayo Clinic in Arizona
John Dibaise, MD
Mayo Clinic in Arizona
Norio Fukami, MD
Mayo Clinic in Arizona
Tasneem Naqvi, MD, MMM
Mayo Clinic in Arizona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”